| Size | Price | Stock | Qty |
|---|---|---|---|
| 5mg |
|
||
| 10mg |
|
||
| 25mg |
|
||
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
|
| Targets |
FPR1; FPR2/ALX
|
|---|---|
| ln Vitro |
FPR Agonist 43 (10-5-107 nM) exhibits active potency in the cAMP assay in FPR2/ALX over-expressing CHO cells[1].
FPR Agonist 43 is also active (IC50=207±51 nM) in the GTPγ binding assay[1]. FPR1 is the preferred receptor for FPR Agonist 43 in human neutrophils as well as possibly in mouse cells[2]. |
| Cell Assay |
Cell Line: Chinese hamster ovary (CHO) over-expressing human FPR2/ALX receptors
Concentration: 10-5, 10-3, 0.1, 10, 1000, 105, 107 nM Result: Actively potent in the cAMP assay in FPR2/ALX over-expressing CHO cells (IC50 =11.6±1.9 nM). |
| References |
| Molecular Formula |
C20H21CLN4O2
|
|---|---|
| Molecular Weight |
384.859343290329
|
| Exact Mass |
384.14
|
| Elemental Analysis |
C, 62.42; H, 5.50; Cl, 9.21; N, 14.56; O, 8.31
|
| CAS # |
903895-98-7
|
| PubChem CID |
24776341
|
| Appearance |
White to light yellow solid powder
|
| LogP |
4.1
|
| Hydrogen Bond Donor Count |
2
|
| Hydrogen Bond Acceptor Count |
3
|
| Rotatable Bond Count |
4
|
| Heavy Atom Count |
27
|
| Complexity |
593
|
| Defined Atom Stereocenter Count |
0
|
| InChi Key |
CCLSQFCCNKQZLZ-UHFFFAOYSA-N
|
| InChi Code |
InChI=1S/C20H21ClN4O2/c1-13(2)17-18(24(20(22)27)15-11-9-14(21)10-12-15)19(26)25(23(17)3)16-7-5-4-6-8-16/h4-13H,1-3H3,(H2,22,27)
|
| Chemical Name |
N-(4-Chlorophenyl)-N-[2,3-dihydro-1-methyl-5-(1-methylethyl)-3-oxo-2-phenyl-1H-pyrazol-4-yl]-urea
|
| Synonyms |
TC-FPR-43; TC FPR 43; TCFPR43
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment, avoid exposure to moisture. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
DMSO: ~37.5 mg/mL (~97.4 mM)
H2O: < 0.1 mg/mL |
|---|---|
| Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.08 mg/mL (5.40 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 20.8 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly. (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.5983 mL | 12.9917 mL | 25.9835 mL | |
| 5 mM | 0.5197 mL | 2.5983 mL | 5.1967 mL | |
| 10 mM | 0.2598 mL | 1.2992 mL | 2.5983 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
